Navigation Links
Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
Date:4/29/2008

- First 15 Patients Are Enrolled and Dosing With Bavituximab Plus Docetaxel

Combination Regimen is Underway -

TUSTIN, Calif., April 29 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus infection (HCV), today announced that it has completed enrollment in the first stage of its Phase II trial of bavituximab in combination with chemotherapy in patients with advanced breast cancer. The main objective of the safety and efficacy study is to assess the overall response rate to the combination of bavituximab with docetaxel, a chemotherapy drug commonly used to treat breast cancer.

"We are very pleased that patient enrollment in this trial has proceeded quickly, reflecting the enthusiasm and efficiency of our clinical colleagues in Europe and the level of patient interest in a potential new therapy for this difficult disease," said Steven W. King, president and CEO of Peregrine. "We look forward to providing an update on the trial as patients continue to be dosed in the study and tumor response data is generated."

As part of this trial's two-stage design, 15 patients with locally advanced or metastatic breast cancer have been enrolled initially. The primary objective of the multi-center, open-label study is to assess overall tumor response rate to the combination of bavituximab with docetaxel. The study may be expanded to include up to an additional 31 subjects if promising results are seen in the first 15 patients. Patients enrolled in the trial will remain in the study until disease progression.

Secondary objectives of the Phase II study include measur
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
2. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
3. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
4. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
8. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
9. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
10. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
11. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 17, 2013 Perrigo Company (NYSE: ... a definitive agreement to acquire and has completed the ... portfolio from Fera Pharmaceuticals, LLC and its affiliates (Fera), ... -based specialty pharmaceutical company. The acquired portfolio, including nine ... net revenues during calendar year 2012. Terms of the ...
(Date:6/17/2013)... -- Breezy , a portfolio company of ... week using a platform technology enabling innovative treatment of mouth-cavity ... is being sold in major Israeli pharmacy chains and will ... Israel follows similar successful product launches ... earlier this year, with a repeat order from ...
(Date:6/17/2013)... June 17, 2013 Johnson & Johnson ... definitive agreement to acquire Aragon Pharmaceuticals, Inc., a ... drugs to treat hormonally-driven cancers. ... Aragon,s lead product candidate is a second generation ... development for castration resistant prostate cancer (CRPC). ...
Breaking Medicine Technology:Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million 2Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million 3A Big "LIKE" for Oral Hygiene 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 2Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc. 3
... American Medical Systems® (AMS) (Nasdaq: ... and therapies for male and female pelvic health, today ... Program (STEP) in Europe. The program is designed to ... about solutions for the treatment of erectile dysfunction (ED) ...
... CHICAGO, Jan. 14, 2011   The Cleveland Clinic and ... support the Clinic,s effort to become a clinically integrated ... together the Cleveland Clinic Hospitals, physicians, and more than ... Cleveland Clinic, through its Community Physician Partnership (CPP), recognized ...
Cached Medicine Technology:American Medical Systems Launches STEP Patient Education Program in Europe 2American Medical Systems Launches STEP Patient Education Program in Europe 3Valence Health Selected by Cleveland Clinic to Support Clinical Integration Program 2
(Date:6/18/2013)... The new swab, designed for infants ... the tip allowing for faster collection of infant saliva. ... (SIS) can be tested for cortisol, cotinine, testosterone, ... diameter of the Salimetrics Infant Swab has been increased ... access more saliva in the newborn’s mouth and thereby ...
(Date:6/17/2013)... (PRWEB) June 18, 2013 A ground-breaking ... stroke patients a new rehabilitation treatment. , Constraint ... and offers a new intensive rehabilitation program to help ... those with cerebral palsy and some other neurological conditions. ... “rewires” the brain helping people to improve the use ...
(Date:6/17/2013)... IL (PRWEB) June 17, 2013 The ... after mild traumatic brain injury (MTBI) closely resembles that ... study published online in the journal Radiology. , ... seen in early Alzheimer’s dementia,” said the study’s lead ... the Division of Neuroradiology at the University of Pittsburgh ...
(Date:6/17/2013)... Essential tremor (ET) is the most common ... people in the United States, and millions more worldwide. ... causes ET, there are no medications specifically designed to ... Tremor© is the International Essential Tremor Foundation’s annual research ... cure for this life-altering neurological condition. , “Although millions ...
(Date:6/17/2013)... distribution of white matter brain abnormalities in some patients ... found in early Alzheimer,s dementia, according to a new ... , "Findings of MTBI bear a striking resemblance ... study,s lead author, Saeed Fakhran, M.D., assistant professor of ... of Pittsburgh School of Medicine. "Additional research may help ...
Breaking Medicine News(10 mins):Health News:Salimetrics Redesigns Infant Swab for Faster, Easier Collection 2Health News:Revolutionary Treatment for Stroke Now Available in Western Australia 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3
... researchers at the Mayo Clinic it was found that surgical ... effective when compared to the conventional open surgery. // ... the vagina after a hysterectomy. The results of the surgery ... United States, one out of nine women will undergo hysterectomy, ...
... of bacteria could explain the relationship between periodontal disease ... study published in the Journal of Periodontology. // ... higher in the ACS group for the combination of ... T. denticola. Specifically, the findings suggest that T. denticola, ...
... genetic variation, along with inflammatory factors and smoking, significantly ... degeneration, according to a study.// ,Age-related macular degeneration ... loss in the elderly of the Western world, according ... a role in AMD, and inflammation also may be ...
... migraines with aura (associated neurologic symptoms such as temporary ... attack, ischemic stroke, angina and death due to ischemic ... a migraine history. In contrast, migraine without aura, the ... increased risk of any cardiovascular event. ...
... University of California, Davis, M.I.N.D. Institute have discovered that ... in the amygdala//, a part of the brain involved ... director of the UC Davis M.I.N.D. Institute, and former ... samples of neurons in the amygdala of nine postmortem ...
... decades, parents and pediatricians have relied on humid air to ... common childhood condition that sometimes// sends worried families to the ... the long relied-on remedy has little medical benefit. ... shower in the bathroom. Or you get them to boil ...
Cached Medicine News:Health News:New Laparoscopic Surgery to Correct Vaginal Vault Prolapse Is Effectual Than the Conventional Surgery 2Health News:Link between Periodontal Bacteria and Heart Disease Established 2Health News:Genetic Variation Linked to Age-Related Macular Degeneration 2Health News:Migraines with Aura Associated with Increased Risk for Cardiovascular Disease 2Health News:Researchers Find Fewer Neurons in the Amygdala of Males with Autism 2Health News:Researchers Find Fewer Neurons in the Amygdala of Males with Autism 3Health News:Humid Air is Little Help for Croup's Barking Cough 2Health News:Humid Air is Little Help for Croup's Barking Cough 3
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
Medicine Products: